The choice of treatment for pulmonary hypertension (PH) requires the assessment of the clinical severity of the disease and the identification of any underlying causes. Patients who have PH secondary to a medical condition such as left heart failure, lung diseases, or thromboembolic disease (PH group 2, 3, and 4 respectively) should receive treatment for the underlying cause. Patients who have pulmonary arterial hypertension (PAH) must undergo vasoreactivity testing in order to assist in the selection of the optimal therapy which includes calcium channel blockers, endothelin receptor antagonist, phosphodiesterase inhibitors, or prostanoids.
Pulmonary hypertension medical therapy
Cardiomegaly medical therapy
Right heart failure medical therapy
Portopulmonary hypertension medical therapy
Pulmonic regurgitation treatment
Pulmonary embolism medical therapy
Eisenmenger’s syndrome medical therapy
Hypertrophic cardiomyopathy interventions